Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY: NVO )

88.08 +4.34 (+5.18%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,128,948
Open 88.39
Bid (Size) 88.01 (1)
Ask (Size) 88.20 (11)
Prev. Close 83.74
Today's Range 85.74 - 89.23
52wk Range 77.82 - 148.15
Shares Outstanding N/A
Dividend Yield 1.16%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
Pfizer has discontinued Beqvez for hemophilia B due to low patient demand and will focus on alternative treatments, including its approved therapy, Hympavzi. 
Via Benzinga
Why Novo Nordisk Stock Popped on Friday
Via The Motley Fool

Performance

YTD
+0.64%
+0.64%
1 Month
+9.32%
+9.32%
3 Month
-16.16%
-16.16%
6 Month
-35.69%
-35.69%
1 Year
-29.26%
-29.26%

More News

Read More
Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Via Investor's Business Daily
Exposures Product Safety
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
Via Benzinga
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Important Insights From Novo Nordisk's Earnings Call
Via The Motley Fool
A Closer Look at Novo Nordisk's Options Market Dynamics
Via Benzinga
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
Via The Motley Fool
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
From Faruqi & Faruqi LLP
Via GlobeNewswire
Novo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Digging Into What Hershey and Eli Lilly Told Investors
Via The Motley Fool
How Is The Market Feeling About Novo Nordisk?
Via Benzinga
Why Novo Nordisk Stock Keeps Going Down
Via The Motley Fool
Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
3 Hot Stocks That Have Already Doubled in 2025
Via The Motley Fool
NOVO NORDISK A/S (NYSE: NVO) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Via Benzinga
Exposures Product Safety
These 3 Stocks Just Announced Major Dividend Hikes
Via MarketBeat
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
Via MarketBeat
NVO STOCK NEWS: NVO Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Novo Nordisk A/S
From Robbins LLP
Via GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO
From The Rosen Law Firm PA
Via GlobeNewswire
Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
Via The Motley Fool
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.